Cardiology News
Get updates on cardiology with press releases highlighting research, treatments, and innovations advancing heart health and cardiovascular medicine. Explore developments influencing cardiology and opportunities in medical advancements and heart disease prevention.
May 8, 2026 at 7:00 AM
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans to participate in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, NV. Pulse Biosciences’ Management is scheduled to present on Wednesday, May 13, at 4:35 pm PT. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the...
May 7, 2026 at 4:01 PM
Arrowhead Pharmaceuticals Reports Fiscal 2026 Second Quarter Results
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2026 second quarter ended March 31, 2026. The Company is hosting a conference call today, May 7, 2026, at 4:30 p.m. ET to discuss the results. “Arrowhead continues to show strong execution in meeting and exceeding our commercial, R&D, and corporate goals. The company is on extremely strong footing to continue to drive growth in the near-term with numerous opport...
May 7, 2026 at 4:00 PM
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, commercial-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today reported financial and recent operational results for the first quarter ended March 31, 2026. “During the first quarter, we continued advancing our cardiovascular gene therapy portfolio, including reinitiating dosing in the initial three-patient cohort of our p...
May 7, 2026 at 2:07 PM
Reprieve Cardiovascular Announces Publication of FASTR Pilot Trial Results in JACC: Heart Failure
MILFORD, Mass.--(BUSINESS WIRE)--FASTR Pilot Study Published in JACC: HF...
May 7, 2026 at 10:15 AM
Elucid’s Plaque-IQ™ Named “Best New Cardiology Technology Solution” in 2026 MedTech Breakthrough Awards Program
BOSTON--(BUSINESS WIRE)--Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therapeutic decisions, today announced that its Plaque-IQ arterial plaque analysis software has been selected as winner of the “Best New Cardiology Technology Solution” award in the 10th annual MedTech Breakthrough Awards. The awards program is conducted by MedTech Breakthrough, an independent market intelligence organization tha...
May 7, 2026 at 10:15 AM
AccurKardia’s AK+ Guard™ Named “Best New ECG Technology Solution” By MedTech Breakthrough
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of the “Best New ECG Technology Solution” award in the 10th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. AI-powered AK+ Guard hyperkale...
May 7, 2026 at 10:00 AM
Welldoc Named “Best Overall Digital Health Company” For Fourth Consecutive Year in 10th Annual MedTech Breakthrough Awards Program
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, an AI-powered health technology leader, today announced that it has been named winner of the “Best Overall Digital Health Company” award for the fourth consecutive year in the MedTech Breakthrough Awards. The annual awards program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the most innovative companies, technologies and products in the global digital health and medical technology market. This is...
May 7, 2026 at 9:15 AM
Elation Health Integrates New American Heart Association and American College of Cardiology Cardiovascular Risk Standard
SAN FRANCISCO--(BUSINESS WIRE)--Elation Health, the clinical-first technology platform for modern primary care success, today announced it has licensed the American Heart Association PREVENTTM risk calculator to be embedded within Clinical Insights, its AI-powered clinical decision support tool within its EHR platform. The American Heart Association and American College of Cardiology (ACC) along with nine other medical colleges released updated cholesterol and lipid management guidelines making...
May 7, 2026 at 9:01 AM
Lantern Pharma Unveils Roadmap for withZeta.ai — Industry-First, Multi-Agentic Co-Scientist Featuring Swarm Intelligence and Computational Biology Toolkit with the Launch of ZetaSwarm™ and ZetaOmics™
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage AI-driven precision oncology company, today unveiled the next phase of its development roadmap for withZeta.ai, the company’s multi-agentic A.I. co-scientist platform for oncology research and drug discovery. Future development plans for release in the coming year include three major capability tracks: ZetaSwarm™, an autonomous multi-agent swarm intelligence layer; ZetaOmics™, a real-time computational biology and mul...
May 7, 2026 at 8:31 AM
HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice
SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.